Injectable enzyme appears effective in treating Peyronie's disease

An investigational injectable enzyme known as AA4500 appears to be effective and generally well tolerated in treating patients with Peyronie's disease, according to data from two phase II open-label trials presented at the recent AUA Western Section annual meeting in Maui, HI.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.